Emtrix® is used to treat discolored and deformed nails resulting from fungal infection or psoriasis. The product was launched in the Nordic countries during autumn 2010 under the Nalox™ brand. International launch is under way through partners in more than 50 countries.
Emtrix is a solution applied to the damaged nail. Nalox/Naloc is patented, and is based on proven compounds. Emtrix is available without prescription under the trademark Nalox™/ Naloc™ in some countries and as Kerasal® Nail™ in USA. Its effect and safety have been documented in several clinical trials including more than 600 patients. Emtrix has a unique rapid mechanism of action and has demonstrated strong competitive results, including visible improvements already within 2-4 weeks.